Exploiting the Warburg Effect: Co‐Delivery of Metformin and FOXK2 siRNA for Ovarian Cancer Therapy

Funding

W.Z., X.M., and J.X. contributed equally to this work. The authors extend their heartfelt gratitude to the Hubei Key Laboratory of Embryonic Stem Cell Research and the Hubei Provincial Clinical Research Center for Umbilical Cord Blood Hematopoietic Stem Cells at Taihe Hospital, Hubei University of Medicine, Shiyan, 44200, China, for their invaluable assistance in the analysis of TCGA data. Cell imaging and flow cytometry were carried out at the Turku Bioscience Centre's cell imaging and cytometry core, which is supported by Biocenter Finland. This work was supported by grants from China Postdoctoral Science Foundation (grant no. 2021M700830), the National Natural Science Foundation of China (grant no. 82201287), the Research Fellow grant (grant no. 353146), the project grant (grant no. 347897) from the Academy of Finland, the Solutions for Health Profile (grant no. 336355), and the InFLAMES Flagship (grant no. 337531). The authors also acknowledge funding from the Finland China Food and Health International Pilot Project, sponsored by the Finnish Ministry of Education and Culture, and the Medical and Health Technology Public Relations Project of Shenzhen Longgang District Science and Technology Innovation Special Fund (LGKCYLWS2022001 to J.F.).